TrialArthritis care & research2019

Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6.

Ronald F van Vollenhoven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.